NL106036C - - Google Patents

Info

Publication number
NL106036C
NL106036C NL240357A NL240357A NL106036C NL 106036 C NL106036 C NL 106036C NL 240357 A NL240357 A NL 240357A NL 240357 A NL240357 A NL 240357A NL 106036 C NL106036 C NL 106036C
Authority
NL
Netherlands
Application number
NL240357A
Inventor
David H Gould
Hans Reimann
Lawrence E Finckenor
Cecil H Robinson
Eugene Oliveto
Elliot L Shapiro
Original Assignee
Scherico Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US743492A external-priority patent/US2894963A/en
Application filed by Scherico Ltd filed Critical Scherico Ltd
Application granted granted Critical
Publication of NL106036C publication Critical patent/NL106036C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL240357A 1958-06-20 1959-06-18 NL106036C (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US743492A US2894963A (en) 1958-06-20 1958-06-20 9,11-dihalogeno-4-pregnenes and 1,4-pregnadienes
CA775651 1959-05-30

Publications (1)

Publication Number Publication Date
NL106036C true NL106036C (cg-RX-API-DMAC7.html) 1963-09-16

Family

ID=25673299

Family Applications (1)

Application Number Title Priority Date Filing Date
NL240357A NL106036C (cg-RX-API-DMAC7.html) 1958-06-20 1959-06-18

Country Status (7)

Country Link
BE (1) BE579900A (cg-RX-API-DMAC7.html)
CH (1) CH386415A (cg-RX-API-DMAC7.html)
DK (1) DK118874B (cg-RX-API-DMAC7.html)
ES (1) ES250249A1 (cg-RX-API-DMAC7.html)
FR (1) FR564M (cg-RX-API-DMAC7.html)
GB (2) GB928301A (cg-RX-API-DMAC7.html)
NL (1) NL106036C (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3397213A (en) * 1966-01-12 1968-08-13 Squibb & Sons Inc 12 methyl-9, 11-dihaloprogesterones
FR2342738A1 (fr) * 1976-03-02 1977-09-30 Roussel Uclaf Nouveaux derives halogenes de la serie du 16a-methyl pregnane
EP2278978B1 (en) 2008-05-28 2015-09-02 ReveraGen BioPharma, Inc. Non-hormonal steroid modulators of nf-kb for treatment of disease
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Also Published As

Publication number Publication date
GB928301A (en) 1963-06-12
FR564M (cg-RX-API-DMAC7.html) 1961-06-05
CH386415A (fr) 1965-01-15
ES250249A1 (es) 1960-01-16
GB928302A (en) 1963-06-12
DK118874B (da) 1970-10-19
BE579900A (fr) 1959-10-16

Similar Documents

Publication Publication Date Title
AT214638B (cg-RX-API-DMAC7.html)
FR564M (cg-RX-API-DMAC7.html)
AT221043B (cg-RX-API-DMAC7.html)
AT217439B (cg-RX-API-DMAC7.html)
JPS381067B1 (cg-RX-API-DMAC7.html)
AT215747B (cg-RX-API-DMAC7.html)
JPS37009162B1 (cg-RX-API-DMAC7.html)
AT213908B (cg-RX-API-DMAC7.html)
AT216227B (cg-RX-API-DMAC7.html)
AT215751B (cg-RX-API-DMAC7.html)
AT213446B (cg-RX-API-DMAC7.html)
AT216771B (cg-RX-API-DMAC7.html)
FR509M (cg-RX-API-DMAC7.html)
AT213631B (cg-RX-API-DMAC7.html)
FR422M (cg-RX-API-DMAC7.html)
AT213670B (cg-RX-API-DMAC7.html)
AT213558B (cg-RX-API-DMAC7.html)
AT213557B (cg-RX-API-DMAC7.html)
AT213472B (cg-RX-API-DMAC7.html)
AT214270B (cg-RX-API-DMAC7.html)
AT213337B (cg-RX-API-DMAC7.html)
AT216612B (cg-RX-API-DMAC7.html)
AT216749B (cg-RX-API-DMAC7.html)
AT215738B (cg-RX-API-DMAC7.html)
AT214348B (cg-RX-API-DMAC7.html)